SE439012B - Forfarande for framstellning av 5-sulfamoyl-ortanilsyror - Google Patents

Forfarande for framstellning av 5-sulfamoyl-ortanilsyror

Info

Publication number
SE439012B
SE439012B SE7804956A SE7804956A SE439012B SE 439012 B SE439012 B SE 439012B SE 7804956 A SE7804956 A SE 7804956A SE 7804956 A SE7804956 A SE 7804956A SE 439012 B SE439012 B SE 439012B
Authority
SE
Sweden
Prior art keywords
acid
group
sulfamoyl
general formula
ester
Prior art date
Application number
SE7804956A
Other languages
English (en)
Swedish (sv)
Other versions
SE7804956L (sv
Inventor
K Sturm
R Muschaweck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7804956L publication Critical patent/SE7804956L/xx
Publication of SE439012B publication Critical patent/SE439012B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SE7804956A 1977-04-28 1978-04-28 Forfarande for framstellning av 5-sulfamoyl-ortanilsyror SE439012B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2718871A DE2718871C3 (de) 1977-04-28 1977-04-28 N-(2-Furylmethyl)-5-sulfamoylorthanilsäuren und deren physiologisch verträgliche Salze und Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Oedemkrankheiten und Bluthochdruck

Publications (2)

Publication Number Publication Date
SE7804956L SE7804956L (sv) 1978-10-29
SE439012B true SE439012B (sv) 1985-05-28

Family

ID=6007484

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7804956A SE439012B (sv) 1977-04-28 1978-04-28 Forfarande for framstellning av 5-sulfamoyl-ortanilsyror

Country Status (18)

Country Link
US (1) US4161533A (nl)
JP (1) JPS53135966A (nl)
AT (1) AT363463B (nl)
BE (1) BE866565A (nl)
CA (1) CA1109477A (nl)
CH (1) CH638798A5 (nl)
DE (1) DE2718871C3 (nl)
DK (1) DK183678A (nl)
ES (1) ES469058A1 (nl)
FI (1) FI65996C (nl)
FR (1) FR2388809A1 (nl)
GB (1) GB1587105A (nl)
HU (1) HU177454B (nl)
IL (1) IL54585A (nl)
IT (1) IT1094565B (nl)
NL (1) NL7804558A (nl)
SE (1) SE439012B (nl)
ZA (1) ZA782421B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3009229A1 (de) * 1980-03-11 1981-10-15 Hoechst Ag, 6000 Frankfurt 2,4-diamino-5-sulfamoylbenzolsulfosaeuren und verfahen zu ihrer herstellung
DE3034880A1 (de) * 1980-09-16 1982-04-29 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von 5- sulfamoyl-orthanilsaeuren
FR2614619B1 (fr) * 1987-04-29 1989-09-15 Sanofi Sa Procede de preparation de n-((chloro-2)-benzyl) (thienyl-2)-2 ethylamine
AU2005216879B2 (en) * 2004-02-20 2009-12-10 Aventis Pharmaceuticals Inc Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1802208U (de) 1959-10-01 1959-12-17 Hugo Guddar Verschluss fuer pelze aller art.
DE1122541B (de) 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
CH383403A (de) 1960-12-23 1964-10-31 Sandoz Ag Verfahren zur Herstellung von neuen Sulfonamiden
DE1278443C2 (de) 1963-11-30 1975-07-24 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-disulfonamid-1-chlorbenzolen
DE1543602C3 (de) 1966-06-16 1974-09-26 Bayer Ag, 5090 Leverkusen Substituierte Disulfonamide sowie deren Salze mit nichttoxischen Basen und Verfahren zu ihrer Herstellung
US3454562A (en) * 1966-10-07 1969-07-08 Smithkline Corp 5 - carbamoylsulfamoyl - n - substitutedanthranilic acids and esters thereof
DE1802208A1 (de) * 1968-10-10 1970-05-14 Hoechst Ag Verfahren zur Herstellung salidiuretisch wirksamer Sulfamylanthranilsaeuren
US3875150A (en) 1969-04-29 1975-04-01 Leo Pharm Prod Ltd New sulfamyl-anthranilic acids
DE2247828A1 (de) 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL54585A (en) 1982-05-31
CH638798A5 (de) 1983-10-14
IT1094565B (it) 1985-08-02
BE866565A (fr) 1978-10-30
AU3548678A (en) 1979-11-01
ZA782421B (en) 1979-04-25
FR2388809B1 (nl) 1980-10-31
FI65996B (fi) 1984-04-30
AT363463B (de) 1981-08-10
DK183678A (da) 1978-10-29
ES469058A1 (es) 1978-11-16
HU177454B (en) 1981-10-28
US4161533A (en) 1979-07-17
FR2388809A1 (fr) 1978-11-24
DE2718871A1 (de) 1978-11-09
CA1109477A (en) 1981-09-22
ATA305278A (de) 1981-01-15
DE2718871C3 (de) 1980-07-17
IT7822729A0 (it) 1978-04-26
GB1587105A (en) 1981-04-01
JPS53135966A (en) 1978-11-28
IL54585A0 (en) 1978-07-31
DE2718871B2 (de) 1979-10-31
FI65996C (fi) 1984-08-10
FI781305A (fi) 1978-10-29
NL7804558A (nl) 1978-10-31
SE7804956L (sv) 1978-10-29

Similar Documents

Publication Publication Date Title
Kurzmeier et al. Abiotic anion receptor functions. A facile and dependable access to chiral guanidinium anchor groups
SE414402B (sv) Sett att framstella alkyl-bensimidazol-karbamater
DK159680B (da) Cycliske imider til anvendelse ved fremstilling af cycliske aminosyrer
Brink et al. Vitamin B12. X. 5, 6-Dimethylbenzimidazole, a degradation product of vitamin B12
PL93943B1 (nl)
PT90080B (pt) Processo para a preparacao de novos derivados acetilenicos, ciano e alenicos de aristeromicina/adenosina
WO2015125572A1 (ja) チオピラノース化合物およびその製造方法
JPH01242571A (ja) イミダゾール誘導体の製造方法
SE439012B (sv) Forfarande for framstellning av 5-sulfamoyl-ortanilsyror
CZ20013658A3 (cs) Syntéza a krystalizace sloučenin obsahujících piperazinový kruh
JPH04300892A (ja) パートリシン誘導体
US5583225A (en) Syntheses of acyclic guanine nucleosides
US3872082A (en) Substituted purineribofuranoside-3,5-cyclophosphate compounds and process for their preparation
JPS5857373A (ja) L−アスコルビン酸誘導体の製法
US6545149B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
Welch et al. Synthesis of an mRNA fragment of alanyl-tRNA synthetase gene in Escherichia coli using the 6-methyl-3-pyridyl group for protection of the imide functions of uridine and guanosine
KR810001154B1 (ko) 5-설파모일-오르트아닐린산의 제조방법
EP0018732B1 (en) An alpha-methyl-4(2'-thienyl-carbonyl)phenyl acetic acid derivative, process for its preparation and its pharmaceutical use
US6320079B1 (en) Process for the preparation of S(ω-aminoalkylamino) alkyl aryl sulfide dihydrochlorides
StanleyáMcElhinney Nucleoside analogues. Part 10. Synthesis of three unusual 5-fluorouracil seco-nucleosides incorporating N-(2-chloroethyl)-N-nitrosourea residues
KR820001082B1 (ko) 모라노린 유도체의 제조방법
CS252564B1 (cs) Způsob výroby 2-merkaptoethansulfonové kyseliny
RU1794941C (ru) N(3-Нитро-4-хлорфенилсульфонил)-5-хлор-антранилова кислота в качестве промежуточного продукта дл получени N-(4-хлорфенил)-2(3-нитро-4-хлор-фенилсульфонил)амино-5-хлорбензамида, обладающего противотрихоцефалезной активностью
JPS5935400B2 (ja) 5−ニトロイミダゾ−ル誘導体の製造法
Khalifa et al. Synthesis and evaluation of novel 6-(3, 5-dimethylbenzyl) uracil analogs as potential anti-HIV-1 agents

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7804956-6

Effective date: 19880822

Format of ref document f/p: F